Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Open Label Study of Optaflu in Healthy Adults
2011-006277-25Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of influenza vaccine in influenza, sponsored by Novartis. Primary endpoints: Immunogenicity endpoints and Safety endpoints. Started Mar 2012; status: completed.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2011-006277-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006277-25.